Abstract
PurposeThe introduction of breast screening in the UK led to an increase in the detection of non-invasive breast neoplasia, predominantly ductal carcinoma in situ (DCIS), a non-obligatory precursor of invasive breast cancer. The Sloane Project, a UK prospective cohort study of screen-detected non-invasive breast neoplasia, commenced in 2003 to evaluate the radiological assessment, surgical management, pathology, adjuvant therapy and outcomes for non-invasive breast neoplasia. Long-term follow-up and accurate data collection are essential to examine the clinical impact. Here, we describe the establishment, development and analytical processes for this large UK cohort study.ParticipantsWomen diagnosed with non-invasive breast neoplasia via the UK National Health Service Breast Screening Programme (NHSBSP) from 01 April 2003 are eligible, with a minimum age of 46 years. Diagnostic, therapeutic and follow-up data collected via proformas, complement date and cause of death from national data sources. Accrual for patients with DCIS ceased in 2012 but is ongoing for patients with epithelial atypia/in situ neoplasia, while follow-up for all continues long term.Findings to dateTo date, patients within the Sloane cohort comprise one-third of those diagnosed with DCIS within the NHSBSP and are representative of UK practice. DCIS has a variable outcome and confirms the need for longer-term follow-up for screen-detected DCIS. However, the radiology and pathology features of DCIS can be used to inform patient management. We demonstrate validation of follow-up information collected from national datasets against traditional, manual methods.Future plansConclusions derived from the Sloane Project are generalisable to women in the UK with screen-detected DCIS. The follow-up methodology may be extended to other UK cohort studies and routine clinical follow-up. Data from English patients entered into the Sloane Project are available on request to researchers under data sharing agreement. Annual follow-up data collection will continue for a minimum of 20 years.
Reference63 articles.
1. NHS, 2018. Available: https://www.nhs.uk/conditions/breast-cancer-screening/when-its-offered/ [Accessed 20 Sep 2021].
2. Age X trial, 2020. Oxford. Available: http://www.agex.uk/about [Accessed 20 Sep 2021].
3. Two-view mammography at the incident round has improved the rate of screen-detected breast cancer in Wales;Osborn;Clin Radiol,2006
4. Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme;Dibden;Br J Cancer,2014
5. The National Archives, 2015. Available: http://webarchive.nationalarchives.gov.uk/20150506150512/http://cancerscreening.nhs.uk/breastscreen/digital-mammography.html [Accessed 20 Sep 2021].
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献